Drug Profile
P1A
Alternative Names: Beta-lactamase capsule - Ipsat; Bioengineered β-lactamase - Ipsat; Ipsat P1ALatest Information Update: 14 Oct 2022
Price :
$50
*
At a glance
- Originator Ipsat Therapies
- Class Antibacterials; Enzymes
- Mechanism of Action Beta lactamase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Intestinal infections